TheClinical Evaluation of QTc Interval Prolongation for the Dual Endothelin Receptor Antagonist Aprocitentan in a Thorough QT/QTc Study

Authors
Category Primary study
ConferenceClinical Pharmacology in Drug Development
Year 2022
This article has no abstract
Epistemonikos ID: 2343f7bb94904a1019ea64f7c61a35775ab83318
First added on: Apr 30, 2026